StockData
Carlsmed, Inc. logo

Carlsmed, Inc. (CARL) shareholders

CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30118% above fair value
$17.74+0.39 (+2.25%)

Close on Nov 17, 2026Market cap $484.35MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
20.9%
6M of 27M shares
Institutional holders
75
24 new, 13 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
0 buys · 5 sales
Net sold $2.66M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
B Capital Group Management, L.P.
Joint filing with B Capital Global Growth III, L.P. (18.90%), B Capital Healthcare I, L.P. (8.90%)
7,390,31127.80%13G (passive)Sep 30, 2025
Casey M Tansey
Joint filing with Presidio Management Group XII, L.L.C. (21.20%), U.S. Venture Partners XII, L.P. (16.20%)
5,842,07322.00%13G (passive)Jul 24, 2025
Michael Cordonnier1,597,7525.90%13G (passive)Jul 24, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of CARLValueChange% of portfolio
Jupiter Topco LLC1,251,6164.58%$12.99MNew0.01%
Parkman Healthcare Partners LLC597,3182.19%$6.20M+76,1950.63%
BlackRock, Inc.532,5931.95%$5.53M+85,7010.00%
KCM Capital Inc440,0001.61%$4.57M+240,0000.74%
Pier Capital, LLC373,6771.37%$3.88MNew0.51%
Millennium Management LLC295,9071.08%$3.07MNew0.00%
Palumbo Wealth Management LLC267,2980.98%$2.77MNew0.58%
Vanguard Capital Management LLC238,7270.87%$2.48M−37,4040.00%
Schonfeld Strategic Advisors LLC224,8040.82%$2.33M−58,3760.01%
Geode Capital Management, LLC204,6550.75%$2.13M+11,4820.00%
Russell Investments Group, Ltd.139,1420.51%$1.44M−20,1490.00%
State Street Corp133,0830.49%$1.38M+19,3660.00%
Citadel Advisors LLC101,7260.37%$1.06M+57,1310.00%
Aqr Capital Management LLC92,1590.34%$956.61KNew0.00%
Jane Street Group, LLC73,3890.27%$761.78K+58,3530.00%
Northern Trust Corp64,6330.24%$670.89K+10,1570.00%
Goldman Sachs Group Inc63,1260.23%$655.25K+40,4880.00%
D. E. Shaw & Co., Inc.60,4390.22%$627.36KNew0.00%
Vanguard Portfolio Management LLC56,9480.21%$591.12K+9,3040.00%
Kornitzer Capital Management Inc /Ks51,6880.19%$536.52K−1,7440.01%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026756M20.9%24 / 3212 / 133M2M
Q1 2026665M19.4%21 / 1618 / 112M1M
Q4 2025575M17.1%16 / 1910 / 71M1M
Q3 2025485M17.1%48 / 00 / 05M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

78 funds held CARL in Q2 2026, 29% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of CARLValue% of fundAs of
Janus Henderson Venture Fund609,0592.23%$6.32M0.17%Jun 30, 2026
Janus Henderson Small Cap Value Fund343,5791.26%$3.57M0.28%Jun 30, 2026
iShares Russell 2000 ETF213,0410.78%$2.21M0.00%Jun 30, 2026
Vanguard Total Stock Market Index Fund158,5830.58%$1.65M0.00%Jun 30, 2026
U.S. Small Cap Equity Fund102,8930.38%$1.30M0.13%Jul 31, 2026
Fidelity Small Cap Index Fund93,1170.34%$1.17M0.00%Jul 31, 2026
Vanguard Extended Market Index Fund73,4870.27%$762.80K0.00%Jun 30, 2026
Adara Smaller Companies Fund59,7250.22%$682.06K0.08%May 31, 2026
Janus Henderson Small-Mid Cap Value Fund54,7810.20%$568.63K0.79%Jun 30, 2026
Dunham Small Cap Growth Fund51,8170.19%$652.38K0.82%Jul 31, 2026
Buffalo Early Stage Growth Fund51,4530.19%$534.08K0.71%Jun 30, 2026
iShares Russell 2000 Growth ETF44,4510.16%$461.40K0.00%Jun 30, 2026
Dunham Small Cap Value Fund43,9230.16%$552.99K0.60%Jul 31, 2026
iShares Russell 2000 Value ETF41,7370.15%$433.23K0.00%Jun 30, 2026
Vanguard Russell 2000 Index Fund41,4080.15%$472.88K0.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Michael CordonnierCEO, President, Director1,517,2135.56%Mar 4, 2026
Niall CaseyChief IP Officer, Director982,5623.60%Jan 30, 2026
Jeffrey BertoliniChief Operating Officer22,4890.08%Nov 4, 2026
Jennifer KamocsayChief Legal Officer56,2220.21%Sep 30, 2026
Richard HeppenstallCFO, Treasurer89,2860.33%Sep 30, 2026
William Scott DurallChief Commercial Officer44,9770.16%Jan 30, 2026
Leonard M. GreensteinCFO, Treasurer188,3460.69%Jan 30, 2026
Kevin SidowDirector73,2640.27%Jun 22, 2026
Jonathan D. RootDirector716,2212.62%Jun 22, 2026
Kevin C. OboyleDirector31,0310.11%Jun 22, 2026
Philip M. YoungDirector84,3640.31%Jun 22, 2026
Robert Mittendorff IIDirector5,013,83918.36%Jul 24, 2025
Presidio Management Group XII, L.L.C.10% owner3,773,92913.82%Sep 15, 2026
Casey M. Tansey10% owner200,0000.73%Sep 15, 2026
U.S. Venture Partners XII, L.P.10% owner––Sep 15, 2026
B Capital Healthcare I, L.P.10% owner6,988,43025.60%Jul 24, 2025
B Capital Group Management, L.P.10% owner––Jul 24, 2025
B Capital Global Growth III, L.P.10% owner––Jul 24, 2025
Hornet Co-Invest Investors, Ltd.10% owner––Jul 24, 2025
Hornet Co-Invest, LP10% owner––Jul 24, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Jeffrey Bertolini
Chief Operating Officer
Nov 3, 2026Sale(10b5-1 plan)−747$15.15$11.32K22,489
Jeffrey Bertolini
Chief Operating Officer
Nov 3, 2026Option exercise+747$5.92$4.42K23,236
Jeffrey Bertolini
Chief Operating Officer
Oct 30, 2026Sale(10b5-1 plan)−243$15.80$3.84K22,489
Jeffrey Bertolini
Chief Operating Officer
Oct 30, 2026Option exercise+243$2.23$54222,732
Jeffrey Bertolini
Chief Operating Officer
Oct 5, 2026Sale(10b5-1 plan)−747$14.39$10.75K22,489
Jeffrey Bertolini
Chief Operating Officer
Oct 5, 2026Option exercise+747$5.92$4.42K23,236
Jeffrey Bertolini
Chief Operating Officer
Sep 30, 2026Sale(10b5-1 plan)−243$13.99$3.40K22,489
Jeffrey Bertolini
Chief Operating Officer
Sep 30, 2026Option exercise+243$2.23$54222,732
Richard Heppenstall
CFO, Treasurer
Sep 28, 2026Award+89,286––89,286
Jonathan D. Root
Director
Jun 3, 2026Award+13,698––497,697
Philip M. Young
Director
Jun 3, 2026Award+13,698––31,031
Kevin Sidow
Director
Jun 3, 2026Award+13,698––73,264
Kevin C. Oboyle
Director
Jun 3, 2026Award+13,698––31,031
Michael Cordonnier
CEO, President, Director
Mar 3, 2026Option exercise+160,567$0.34$54.59K1,517,213
Michael Cordonnier
CEO, President, Director
Mar 3, 2026Option exercise+33,264$4.35$144.70K1,550,477
Michael Cordonnier
CEO, President, Director
Mar 2, 2026Sale−197,855$13.29$2.63M1,356,646
Michael Cordonnier
CEO, President, Director
Mar 2, 2026Option exercise+197,855$0.34$67.27K1,554,501
Leonard M. Greenstein
CFO, Treasurer
Jan 28, 2026Award+44,977––188,346
William Scott Durall
Chief Commercial Officer
Jan 28, 2026Award+44,977––44,977
Michael Cordonnier
CEO, President, Director
Jan 28, 2026Award+117,316––1,356,646
Niall Casey
Chief IP Officer, Director
Jan 28, 2026Award+44,977––982,562
Casey M. Tansey
10% owner
Jul 24, 2025Buy+200,000$15.00$3.00M200,000
Philip M. Young
Director
Jul 24, 2025Buy+53,333$15.00$800.00K53,333
Philip M. Young
Director
Jul 24, 2025Conversion+28,900––28,900
Philip M. Young
Director
Jul 24, 2025Buy+6,666$15.00$99.99K35,566
Robert Mittendorff II
Director
Jul 24, 2025Buy+1,333,333$15.00$20.00M5,013,839
Robert Mittendorff II
Director
Jul 24, 2025Conversion+2,376,472––2,376,472
Robert Mittendorff II
Director
Jul 24, 2025Conversion+931,452––931,452
Robert Mittendorff II
Director
Jul 24, 2025Conversion+3,680,506––3,680,506
Kevin Sidow
Director
Jul 24, 2025Buy+13,333$15.00$200.00K59,566
Kevin Sidow
Director
Jul 24, 2025Option exercise+28,900––28,900
Niall Casey
Chief IP Officer, Secretary, Director
Jul 24, 2025Option exercise+3,612––937,585
Michael Cordonnier
CEO, President, Director
Jul 24, 2025Option exercise+3,612––1,239,330
Jonathan D. Root
Director
Jul 24, 2025Conversion+26,993––218,524
Jonathan D. Root
Director
Jul 24, 2025Conversion+1,117,743––1,117,743
Jonathan D. Root
Director
Jul 24, 2025Buy+466,666$15.00$7.00M483,999
Jonathan D. Root
Director
Jul 24, 2025Conversion+2,948,794––2,948,794
Jonathan D. Root
Director
Jul 24, 2025Conversion+825,135––3,773,929
Jonathan D. Root
Director
Jul 24, 2025Conversion+531,877––4,305,806
Jonathan D. Root
Director
Jul 24, 2025Conversion+149,655––149,655
Jonathan D. Root
Director
Jul 24, 2025Conversion+41,876––191,531
B Capital Healthcare I, L.P.
10% owner
Jul 24, 2025Conversion+3,680,506––3,680,506
B Capital Healthcare I, L.P.
10% owner
Jul 24, 2025Conversion+2,376,472––2,376,472
B Capital Healthcare I, L.P.
10% owner
Jul 24, 2025Buy+1,333,333$15.00$20.00M5,013,839
B Capital Healthcare I, L.P.
10% owner
Jul 24, 2025Conversion+931,452––931,452
Presidio Management Group XII, L.L.C.
10% owner
Jul 24, 2025Conversion+825,135––3,773,929
Presidio Management Group XII, L.L.C.
10% owner
Jul 24, 2025Conversion+531,877––4,305,806
Presidio Management Group XII, L.L.C.
10% owner
Jul 24, 2025Conversion+149,655––149,655
Presidio Management Group XII, L.L.C.
10% owner
Jul 24, 2025Conversion+41,876––191,531
Presidio Management Group XII, L.L.C.
10% owner
Jul 24, 2025Conversion+26,993––218,524
Presidio Management Group XII, L.L.C.
10% owner
Jul 24, 2025Conversion+1,117,743––1,117,743
Presidio Management Group XII, L.L.C.
10% owner
Jul 24, 2025Conversion+2,948,794––2,948,794
Philip M. Young
Director
Jul 22, 2025Award+17,333––17,333
Kevin Sidow
Director
Jul 22, 2025Award+17,333––17,333
Kevin C. Oboyle
Director
Jul 22, 2025Award+17,333––17,333
Jonathan D. Root
Director
Jul 22, 2025Award+17,333––17,333

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
24.01%
1M shares short
Days to cover
15.1
At 0M shares a day
Change since last report
+13.4%
From 1M shares
Short volume, 20 days
45.6%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Carlsmed's stock actually held short. Settlement fails (shares not delivered on time) peaked at 528 shares on Oct 14, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Jeffrey Bertolini
Officer
Nov 3, 2026747$11.32KNov 3, 2026Stock Option Exercise
Jeffrey Bertolini
Officer
Oct 30, 2026243$3.84KOct 30, 2026Stock Option Exercise
Leonard M. Greenstein
Former Officer
Oct 14, 20264,136$57.87KOct 14, 2026Restricted Stock Vesting
Jeffrey Bertolini
Officer
Oct 5, 2026747$10.75KOct 5, 2026Stock Option Exercise
Jeffrey Bertolini
Officer
Sep 30, 2026243$3.40KSep 30, 2026Stock Option Exercise
Michael Cordonnier
Officer, Director
Mar 2, 2026197,855$2.63MMar 2, 2026Options Granted - 01/08/2021

See a number that looks wrong?